13 results on '"Martineau, Estelle"'
Search Results
2. Gut bacteria are essential for normal cuticle development in herbivorous turtle ants
- Author
-
Duplais, Christophe, Sarou-Kanian, Vincent, Massiot, Dominique, Hassan, Alia, Perrone, Barbara, Estevez, Yannick, Wertz, John T., Martineau, Estelle, Farjon, Jonathan, Giraudeau, Patrick, and Moreau, Corrie S.
- Published
- 2021
- Full Text
- View/download PDF
3. Extending the Lipidome Coverage by Combining Different Mass Spectrometric Platforms: An Innovative Strategy to Answer Chemical Food Safety Issues
- Author
-
Marchand, Jérémy, primary, Guitton, Yann, additional, Martineau, Estelle, additional, Royer, Anne-Lise, additional, Balgoma, David, additional, Le Bizec, Bruno, additional, Giraudeau, Patrick, additional, and Dervilly, Gaud, additional
- Published
- 2021
- Full Text
- View/download PDF
4. Two data pre-processing workflows to facilitate the discovery of biomarkers by 2D NMR metabolomics
- Author
-
UCL - SSH/LIDAM/ISBA - Institut de Statistique, Biostatistique et Sciences Actuarielles, Feraud, Baptiste, Leenders, Justine, Martineau, Estelle, Giraudeau, Patrick, Govaerts, Bernadette, de Tullio, Pascal, UCL - SSH/LIDAM/ISBA - Institut de Statistique, Biostatistique et Sciences Actuarielles, Feraud, Baptiste, Leenders, Justine, Martineau, Estelle, Giraudeau, Patrick, Govaerts, Bernadette, and de Tullio, Pascal
- Abstract
Introduction The pre-processing of analytical data in metabolomics must be considered as a whole to allow the construction of a global and unique object for any further simultaneous data analysis or multivariate statistical modelling. For 1D 1H-NMR metabolomics experiments, best practices for data pre-processing are well defined, but not yet for 2D experiments (for instance COSY in this paper). Objective By considering the added value of a second dimension, the objective is to propose two workflows dedicated to 2D NMR data handling and preparation (the Global Peak List and Vectorization approaches) and to compare them (with respect to each other and with 1D standards). This will allow to detect which methodology is the best in terms of amount of metabolomic content and to explore the advantages of the selected workflow in distinguishing among treatment groups and identifying relevant biomarkers. Therefore, this paper explores both the necessity of novel 2D pre-processing workflows, the evaluation of their quality and the evaluation of their performance in the subsequent determination of accurate (2D) biomarkers. Methods To select the more informative data source, MIC (Metabolomic Informative Content) indexes are used, based on clustering and inertia measures of quality. Then, to highlight biomarkers or critical spectral zones, the PLS-DA model is used, along with more advanced sparse algorithms (sPLS and L-sOPLS). Results Results are discussed according to two different experimental designs (one which is unsupervised and based on human urine samples, and the other which is controlled and based on spiked serum media). MIC indexes are shown, leading to the choice of the more relevant workflow to use thereafter. Finally, biomarkers are provided for each case and the predictive power of each candidate model is assessed with cross-validated measures of RMSEP. Conclusion In conclusion, it is shown that no solution can be universally the best in every case, but that 2D exp
- Published
- 2019
5. Strategy for choosing extraction procedures for NMR-based metabolomic analysis of mammalian cells
- Author
-
Martineau, Estelle, Tea, Illa, Loaëc, Gregory, Giraudeau, Patrick, and Akoka, Serge
- Published
- 2011
- Full Text
- View/download PDF
6. Two data pre-processing workflows to facilitate the discovery of biomarkers by 2D NMR metabolomics
- Author
-
Feraud, Baptiste, Leenders, Justine, Martineau, Estelle, Giraudeau, Patrick, Govaerts, Bernadette, de Tullio, Pascal, and UCL - SSH/IMMAQ/ISBA - Institut de Statistique, Biostatistique et Sciences Actuarielles
- Subjects
1H-NMR ,2D NMR ,PLS ,sPLS ,Biomarker discovery ,Metabolomic Informative Content (MIC) ,Pre-prossessing workflows ,COSY spectra ,L-sOPLS - Published
- 2018
7. Quantitative in-situ NMR to characterize protein oxidation and its dynamics
- Author
-
Pages, Guilhem, Morisse, Amaël, Gatellier, Philippe, Martineau, Estelle, Giraudeau, Patrick, Bonny, J.-M., Qualité des Produits Animaux (QuaPA), Institut National de la Recherche Agronomique (INRA), Centre National de la Recherche Scientifique (CNRS), and Programme Qualiment Staboxal
- Subjects
résonance magnétique nucléaire ,[SDV.IDA]Life Sciences [q-bio]/Food engineering ,[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering ,qualité des aliments ,oxydation des protéines - Abstract
International audience; Preserving food quality is critical to limit the oxidation processes. The evolution of meat colour or the development of rancid taste in oils are two examples of oxidative processes degrading the food quality. The reaction of oxygen (or its derivatives) with metal ions naturally present in food ( eg. iron) forms free radical reactive oxygen species (ROS). These ROS are the main factors of food oxidation. The aim of this work is to evaluate the intakes of quantitative in situ NMR to understand and characterize the oxidation mechanisms. Our preliminary work focussed on the evaluation of some amino acid mixtures as models of protein oxidation. Due to NMR signal overlaps, recording 2D NMR spectra is indispensable to isolate NMR signals from targeted amino-acids. However, these experiments are time- consuming and not adapted to chemically evolving media. To address this limitation, we developed tailored hybrid methods based on ultrafast 2D NMR. The spectrum recording time decreased from ~30 min for a classical pulse sequence to a few minutes only with the ultrafast method. This approach allows the real-time monitoring of chemical evolutions in such complex mixtures. Using this quantitative approach, we observed a fast oxidation for the histidine while threonine and lysine oxidization kinetics were significantly slower. Our analytical approach offers a promising tool to monitor oxidation processes in food products.
- Published
- 2016
8. C and 15 N natural isotope abundance reflects breast cancer cell metabolism OPEN
- Author
-
Tea, Illa, Martineau, Estelle, Antheaume, Ingrid, Lalande, Julie, Mauve, Caroline, Gilard, Francoise, Barillé-Nion, Sophie, Blackburn, Anneke, Tcherkez, Guillaume, Chimie Et Interdisciplinarité : Synthèse, Analyse, Modélisation (CEISAM), Université de Nantes - Faculté des Sciences et des Techniques, Université de Nantes (UN)-Université de Nantes (UN)-Centre National de la Recherche Scientifique (CNRS), Cancer Metabolism and Genetics Group [Canberra, Australia], Australian National University (ANU)-The John Curtin School of Medical Research, Cellule de compétences SPECTROMAITRISE, Université de Nantes (UN)-Université de Nantes (UN)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - Faculté des Sciences et des Techniques, Plateforme Métabolisme-Métabolome [Orsay], Institut des Sciences des Plantes de Paris-Saclay (IPS2 (UMR_9213 / UMR_1403)), Institut National de la Recherche Agronomique (INRA)-Université d'Évry-Val-d'Essonne (UEVE)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris-Saclay-Université Paris-Sud - Paris 11 (UP11)-Institut National de la Recherche Agronomique (INRA)-Université d'Évry-Val-d'Essonne (UEVE)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris-Saclay-Université Paris-Sud - Paris 11 (UP11), Centre de Recherche en Cancérologie / Nantes - Angers (CRCNA), Centre hospitalier universitaire de Nantes (CHU Nantes)-Faculté de Médecine d'Angers-Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Centre National de la Recherche Scientifique (CNRS)-Hôpital Laennec-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôtel-Dieu de Nantes, Research School of Biology [Canberra, Australia], and Australian National University (ANU)
- Subjects
[SDV.CAN]Life Sciences [q-bio]/Cancer - Abstract
International audience; Breast cancer is the most common cancer in women worldwide. Despite the information provided by anatomopathological assessment and molecular markers (such as receptor expression ER, PR, HER2), breast cancer therapies and prognostics depend on the metabolic properties of tumor cells. However, metabolomics have not provided a robust and congruent biomarker yet, likely because individual metabolite contents are insufficient to encapsulate all of the alterations in metabolic fluxes. Here, we took advantage of natural 13 C and 15 N isotope abundance to show there are isotopic differences between healthy and cancer biopsy tissues or between healthy and malignant cultured cell lines. Isotope mass balance further suggests that these differences are mostly related to lipid metabolism, anaplerosis and urea cycle, three pathways known to be impacted in malignant cells. Our results demonstrate that the isotope signature is a good descriptor of metabolism since it integrates modifications in C partitioning and N excretion altogether. Our present study is thus a starting point to possible clinical applications such as patient screening and biopsy characterization in every cancer that is associated with metabolic changes. Medical applications of stable isotopes are now widespread, like the well-known 13 C-urea breath assay for ulcer detection 1. This takes advantage of 13 C-labelling and thus usually neglects differences in reaction rates between isotopic forms, because the isotopic signal used for diagnosing is far above small natural variations in 13 C. By contrast, the use of isotopes at natural abundance exploits such subtle differences (referred to as isotope effects) to identify bottlenecks in metabolic pathways (rate-limiting steps) or the contribution of multiple elemental sources (mass balance), without the need to introduce expensive isotope tracers into the patient. Isotope effects in metabolism are mostly caused by enzymatic reactions that preferentially consume substrates containing either the light or the heavy isotope (isotopologues) and therefore, the natural isotope abundance in metabolites depends on metabolic fluxes and source substrates 2. For example, the natural 13 C abundance in respired CO 2 has been used to trace diet composition and substrate changes during exercise 3,4. In cancer biology, the use of natural variations in Cu and S stable isotopes in hepatocellular carcinoma has been attempted recently 5. But to our knowledge, no study has looked at alterations of natural isotope abundance in breast cancer. Due to changes in primary C and N metabolism such as increased glycolysis, glutaminolysis and nucleotide synthesis 6 , important changes in 13 C and 15 N natural abundance can be anticipated. To address this question, we examined the isotopic signature of intact breast cancer biopsies (mostly from invasive ductal carcinoma, IDC) and cultured breast cancer cell lines (Supplementary Tables S1 and S2) using elemental analysis coupled to isotope ratio mass spectrometry (EA-IRMS). This technique has been recently shown to be applicable to the biochemical analysis of cancerous cell lines 7 .
- Published
- 2016
9. Multidimensional NMR approaches towards highly resolved, sensitive and high-throughput quantitative metabolomics
- Author
-
Marchand, Jérémy, primary, Martineau, Estelle, additional, Guitton, Yann, additional, Dervilly-Pinel, Gaud, additional, and Giraudeau, Patrick, additional
- Published
- 2017
- Full Text
- View/download PDF
10. 13C and 15N natural isotope abundance reflects breast cancer cell metabolism
- Author
-
Tea, Illa, Martineau, Estelle, Antheaume, Ingrid, Lalande, Julie, Mauve, Caroline, Gilard, Francoise, Barillé-Nion, Sophie, Blackburn, Anneke, Tcherkez, Guillaume, Tea, Illa, Martineau, Estelle, Antheaume, Ingrid, Lalande, Julie, Mauve, Caroline, Gilard, Francoise, Barillé-Nion, Sophie, Blackburn, Anneke, and Tcherkez, Guillaume
- Abstract
Breast cancer is the most common cancer in women worldwide. Despite the information provided by anatomopathological assessment and molecular markers (such as receptor expression ER, PR, HER2), breast cancer therapies and prognostics depend on the metabolic properties of tumor cells. However, metabolomics have not provided a robust and congruent biomarker yet, likely because individual metabolite contents are insufficient to encapsulate all of the alterations in metabolic fluxes. Here, we took advantage of natural 13C and 15N isotope abundance to show there are isotopic differences between healthy and cancer biopsy tissues or between healthy and malignant cultured cell lines. Isotope mass balance further suggests that these differences are mostly related to lipid metabolism, anaplerosis and urea cycle, three pathways known to be impacted in malignant cells. Our results demonstrate that the isotope signature is a good descriptor of metabolism since it integrates modifications in C partitioning and N excretion altogether. Our present study is thus a starting point to possible clinical applications such as patient screening and biopsy characterization in every cancer that is associated with metabolic changes.
- Published
- 2016
11. 13C and 15N natural isotope abundance reflects breast cancer cell metabolism
- Author
-
Tea, Illa, primary, Martineau, Estelle, additional, Antheaume, Ingrid, additional, Lalande, Julie, additional, Mauve, Caroline, additional, Gilard, Francoise, additional, Barillé-Nion, Sophie, additional, Blackburn, Anneke C., additional, and Tcherkez, Guillaume, additional
- Published
- 2016
- Full Text
- View/download PDF
12. 13C and 15N natural isotope abundance reflects breast cancer cell metabolism.
- Author
-
Tea, Illa, Martineau, Estelle, Antheaume, Ingrid, Lalande, Julie, Mauve, Caroline, Gilard, Francoise, Barillé-Nion, Sophie, Blackburn, Anneke C., and Tcherkez, Guillaume
- Published
- 2016
- Full Text
- View/download PDF
13. 13 C and 15 N natural isotope abundance reflects breast cancer cell metabolism.
- Author
-
Tea I, Martineau E, Antheaume I, Lalande J, Mauve C, Gilard F, Barillé-Nion S, Blackburn AC, and Tcherkez G
- Abstract
Breast cancer is the most common cancer in women worldwide. Despite the information provided by anatomopathological assessment and molecular markers (such as receptor expression ER, PR, HER2), breast cancer therapies and prognostics depend on the metabolic properties of tumor cells. However, metabolomics have not provided a robust and congruent biomarker yet, likely because individual metabolite contents are insufficient to encapsulate all of the alterations in metabolic fluxes. Here, we took advantage of natural
13 C and15 N isotope abundance to show there are isotopic differences between healthy and cancer biopsy tissues or between healthy and malignant cultured cell lines. Isotope mass balance further suggests that these differences are mostly related to lipid metabolism, anaplerosis and urea cycle, three pathways known to be impacted in malignant cells. Our results demonstrate that the isotope signature is a good descriptor of metabolism since it integrates modifications in C partitioning and N excretion altogether. Our present study is thus a starting point to possible clinical applications such as patient screening and biopsy characterization in every cancer that is associated with metabolic changes.- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.